Skin Carcinoma — Trials

Skin Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

389 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 127
Recruiting: 69
Ph III recruiting: 8
Growth YoY: +12%
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (52)

clinicaltrialsPublishedShowing 51–100 of 153 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07094685	Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer(SENIOR-HN)	recruiting	Phase 2	28	University of Michigan Rogel Cancer CenterOTHER	1	Jun 26, 2026	clinicaltrials
NCT04358276	Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study	active not recruiting	N/A	840	City of Hope Medical CenterOTHER	1	Jun 25, 2026